Literature DB >> 22302072

Uveal melanoma: the inflammatory microenvironment.

Inge H G Bronkhorst1, Martine J Jager.   

Abstract

Uveal melanoma is a highly malignant intraocular tumor with quite homogeneous tumor tissue and a diffuse leukocytic infiltration. In contrast with many other malignancies, the presence of infiltrating macrophages and T cells is associated with a poor prognosis rather than a good one. The clear link between inflammation and cancer in this malignancy provides a paradigm for macrophage plasticity and function. Macrophages in uveal melanoma have an M2-like phenotype and are associated with the loss of one specific chromosome - monosomy 3. The central players involved in this process and discussed in this review include macrophages, T lymphocytes, chemokines and cytokines, including the macrophage-attraction molecules. When a tumor acquires the ability to release significant amounts of macrophage-attraction molecules it causes the expansion of a population of myeloid immature cells that may not only help the tumor to suppress immune reactions but also aid in the construction of new blood vessels for tumor growth. A better understanding of the molecular basis of a local myelomonocytic cell population will bring a better understanding of the immunopathology of this disease and will lead to therapeutic interventions in uveal melanoma. This review focuses on the roles of the local inflammatory microenvironment in the development and progression of uveal melanoma.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22302072      PMCID: PMC6741452          DOI: 10.1159/000334576

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  32 in total

1.  Innate immune functions of macrophages in different tissue environments.

Authors:  Siamon Gordon
Journal:  J Innate Immun       Date:  2012-06-12       Impact factor: 7.349

2.  Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.

Authors:  Mithalesh Kumar Singh; Lata Singh; Kunzang Chosdol; Neelam Pushker; Neeru Saini; Rachna Meel; Sameer Bakhshi; Seema Sen; Seema Kashyap
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-14       Impact factor: 4.553

Review 3.  Ocular diseases: immunological and molecular mechanisms.

Authors:  Jing Song; Yi-Fei Huang; Wen-Jing Zhang; Xiao-Fei Chen; Yu-Mian Guo
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

Review 4.  Uveal melanoma as a target for immune-therapy.

Authors:  Marc Oliva; Antonio J Rullan; Josep M Piulats
Journal:  Ann Transl Med       Date:  2016-05

5.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

6.  Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.

Authors:  Manisha Singh; Hiep Khong; Zhimin Dai; Xue-Fei Huang; Jennifer A Wargo; Zachary A Cooper; John P Vasilakos; Patrick Hwu; Willem W Overwijk
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

7.  Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns.

Authors:  Hans E Grossniklaus; Qing Zhang; Shuo You; Conni McCarthy; Steffen Heegaard; Sarah E Coupland
Journal:  Hum Pathol       Date:  2016-07-29       Impact factor: 3.466

Review 8.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

9.  Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.

Authors:  Arnaud Pommier; Alexandra Audemard; Aurélie Durand; Renée Lengagne; Arnaud Delpoux; Bruno Martin; Laetitia Douguet; Armelle Le Campion; Masashi Kato; Marie-Françoise Avril; Cédric Auffray; Bruno Lucas; Armelle Prévost-Blondel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

10.  Elevated VEGF-A & PLGF concentration in aqueous humor of patients with uveal melanoma following Iodine-125 plaque radiotherapy.

Authors:  Meng-Xi Chen; Yue-Ming Liu; Yang Li; Xuan Yang; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.